<DOC>
	<DOCNO>NCT03038451</DOCNO>
	<brief_summary>s-amlodipine besylate 2,5 mg tablet administer patient received hypertension treatment receive anti-hypertensive mono-therapy first four week treatment . By increase dose , s-amlodipine besylate 5 mg tablet administer last four week ( 4-8 week ) .</brief_summary>
	<brief_title>Efficacy Safety S-amlodipine 2,5 mg 5 mg Hypertension Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male female outpatient 18 year old . Hypertension patient receive antihypertensive treatment ( ≥ 140 mmHg MSSBP &lt; 160 mmHg , ≥ 90 mmHg MSDBP &lt; 100mmHg ) . Hypertension patient control single medicine . Patients give write informed consent without influence . Pregnant patient , nurse mother female patient potential childbearing use effective contraceptive method . Allergy hypersensitivity dihydropyridines . Patients receive one antihypertensive medicine . Patients seconder hypertension . Patients severe hypertension , myocardial infarction , NYHA stage 24 cardiac insufficiency , history cerebrovascular disease , past ischemic attack , encephalopathy , underwent coronary artery bypass surgery percutaneous coronary intervention , second third degree heart block symptomatic arrhythmia without pacemaker , clinically significant heart valve disease , potential lifethreatening symptomatic arrhythmia , simultaneous unstable angina pectoris , type I diabetes mellitus , atrial fibrillation last 12 month . Uncontrolled type II diabetes mellitus . Patients significant liver disease ( ALT , AST must &gt; 2XULN beginning , patient esophageal varix , portacaval shunt ) . Patients significant kidney disease ( GFR &lt; 60 ml/min accord CockcroftGault formula ) . Patients volume depletion . Patients pancreas disease . Patients gastrointestinal disease may effect absorption . Drug/narcotic alcohol abuse last 12 month . Patients central nervous system disease take medicine reason . History incompatibility medical regime patient want adhere study protocol . Persons directly involved management protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>